References and Notes
<A NAME="RU12408ST-1">1</A>
Present address: School of Pharmaceutical
Sciences, Teikyo University, 1091-1 Suarashi, Sagamiko, Sagamihara,
229-0195, Japan.
<A NAME="RU12408ST-2A">2a</A>
Kim CU.
Lew W.
Williams MA.
Liu H.
Zhang L.
Swaminathan S.
Bischofberger N.
Chen MS.
Mendel DB.
Tai CY.
Laver WG.
Stevens RC.
J. Am. Chem. Soc.
1997,
119:
681
<A NAME="RU12408ST-2B">2b</A>
Rohloff JC.
Kent KM.
Postich MJ.
Becker MW.
Chapman HH.
Kelly DE.
Lew W.
Louie MS.
McGee LR.
Prisbe EJ.
Schultze LM.
Yu RH.
Zhang L.
J.
Org. Chem.
1998,
63:
4545
<A NAME="RU12408ST-2C">2c</A>
Federspiel M.
Fischer R.
Henning M.
Mair H.-J.
Oberhauser T.
Rimmler G.
Albiez T.
Bruhin J.
Estermann H.
Gandert C.
Göckel V.
Götzö S.
Hoffmann U.
Huber G.
Janatsch G.
Lauper S.
Röckel-Stäbler O.
Trusssardi R.
Zwahlen AG.
Org. Process Res. Dev.
1999,
3:
266
<A NAME="RU12408ST-2D">2d</A>
Karpf M.
Trussardi R.
J. Org. Chem.
2001,
66:
2044
<A NAME="RU12408ST-2E">2e</A>
Harrington PJ.
Brown JD.
Foderaro T.
Hughes RC.
Org.
Process Res. Dev.
2004,
8:
86
<A NAME="RU12408ST-3">3</A>
Farina V.
Brown JD.
Angew. Chem. Int. Ed.
2006,
45:
7330
<A NAME="RU12408ST-4A">4a</A>
Yeung Y.-Y.
Hong S.
Corey EJ.
J. Am. Chem. Soc.
2006,
128:
6310
<A NAME="RU12408ST-4B">4b</A>
Fukuta Y.
Mita T.
Fukuda N.
Kanai M.
Shibasaki M.
J. Am.
Chem. Soc.
2006,
128:
6312
<A NAME="RU12408ST-4C">4c</A>
Cong X.
Yao ZJ.
J. Org. Chem.
2006,
71:
5365
<A NAME="RU12408ST-4D">4d</A>
Mita T.
Fukuda N.
Roca FX.
Kanai M.
Shibasaki M.
Org.
Lett.
2007,
9:
259
<A NAME="RU12408ST-4E">4e</A>
Yamatsugu K.
Kamijo S.
Suto Y.
Kanai M.
Shibasaki M.
Tetrahedron
Lett.
2007,
48:
1403
<A NAME="RU12408ST-4F">4f</A>
Bromfield KM.
Graden H.
Hagberg DP.
Olsson T.
Kann N.
Chem. Commun.
2007,
3183
<A NAME="RU12408ST-4G">4g</A>
Satoh N.
Akiba T.
Yokoshima S.
Fukuyama T.
Angew. Chem. Int. Ed.
2007,
46:
5734
<A NAME="RU12408ST-4H">4h</A>
Shie J.-J.
Fang J.-M.
Wang S.-Y.
Tsai K.-C.
Cheng Y.-SE.
Yang
A.-S.
Hsiao S.-C.
Su C.-Y.
Wong C.-H.
J.
Am. Chem. Soc.
2007,
129:
11892
<A NAME="RU12408ST-4I">4i</A>
Trost BM.
Zhang T.
Angew. Chem.
Int. Ed.
2008,
47:
1
<A NAME="RU12408ST-4J">4j</A>
Zutter U.
Iding H.
Spurr P.
Wirz B.
J. Org. Chem.
2008,
73:
4895
<A NAME="RU12408ST-4K">4k</A>
Shie J.-J.
Fang J.-M.
Wong C.-H.
Angew.
Chem. Int. Ed.
2008,
47:
5788
<A NAME="RU12408ST-4L">4l</A>
Satoh N.
Akiba T.
Yokoshima S.
Fukuyama T.
Tetrahedron
2009, in press
<A NAME="RU12408ST-4M">4m</A>
Yamatsugu K.
Yin L.
Kamijo S.
Kimura Y.
Kanai M.
Shibasaki M.
Angew. Chem. Int. Ed.
2009,
48:
1070
Ishikawa H.
Suzuki T.
Hayashi Y.
Angew. Chem.
Int. Ed.
2009,
48:
1304
<A NAME="RU12408ST-5">5</A>
for a recent review on the synthesis
of oseltamivir (1), see: Shibasaki, M.;
Kanai, M. Eur. J. Org. Chem. 2008, 1839; see also ref. 3.
<A NAME="RU12408ST-6">6</A>
Schmid CR.
Bradley DA.
Synthesis
1992,
587
<A NAME="RU12408ST-7">7</A>
The optical purity of 3 was
determined as follows. The HPLC analysis [Chiralcel OD; λ = 254
nm; eluent: hexane-EtOH (9:1); flow rate: 1.3 mL/min] of
3,5-dinitrobenzoate of 3 showed the two
peaks based on their two diastereomers at t
R = 11.4
min and 22.3 min, respectively. On the other hand, those of racemic 3, prepared from glycerol via acetalization, Swern
oxidation, and Grignard reaction, showed four peaks at t
R = 11.4 min, 14.5
min, 18.7 min, and 22.2 min, respectively. This observation surely
indicates that 2 and 3 are
formed without racemization throughout the sequential reactions.
<A NAME="RU12408ST-8">8</A>
Johnson WS.
Werthemann L.
Bartlett WR.
Brocksom TJ.
Li T.-T.
Faulkner DJ.
Petersen MR.
J. Am. Chem. Soc.
1970,
92:
741
<A NAME="RU12408ST-9">9</A>
Compound 4:
colorless oil; [α]D
²¹.6 +24.0
(c 1.23, CHCl3); bp 110-112 ˚C/6.66˙10-4 bar. ¹H
NMR (500 MHz, CDCl3): δ = 5.80 (dt, J = 15.3,
6.4 Hz, 1 H), 5.48 (dd, J = 15.3,
7.9 Hz, 1 H), 4.45 (ddd, J = 8.25,
7.95, 6.1 Hz, 1 H), 4.13 (q, J = 7.0 Hz,
2 H), 4.10 (dd, J = 7.95,
6.1 Hz, 1 H), 3.51 (dd, J = 8.25, 7.95
Hz, 1 H), 2.43-2.36 (m, 4 H), 1.68-1.60 (m, 4
H), 1.25 (t, J = 7.0
Hz, 3 H), 0.95-0.88 (m, 6 H). ¹³C
NMR (125 MHz, CDCl3): δ = 172.7, 133.3,
128.5, 113.0, 77.3, 69.9, 60.3, 33.5, 29.9, 29.8, 27.4, 14.2, 8.1,
8.0. HRMS (EI+):
m/z calcd
for C14H24O4: 256.1675; found:
256.1655.
A solution of ester 4 in
toluene was added dropwise to a solution of DIBAL-H in toluene.
As the relevant papers, see:
<A NAME="RU12408ST-10A">10a</A>
Takano S.
Akiyama M.
Sato S.
Ogasawara K.
Chem. Lett.
1983,
1593
<A NAME="RU12408ST-10B">10b</A>
Mori A.
Fujiwara J.
Maruoka K.
Yamamoto H.
Tetrahedron Lett.
1983,
24:
4581
<A NAME="RU12408ST-11">11</A>
First we prepared a corresponding
dibenzyl ether of 5a, which proved to be
cleaved in a later azide-formation step affording a complex mixture.
<A NAME="RU12408ST-12">12</A>
Sharpless KB.
Amberg W.
Bennani YL.
Crispino
GA.
Hartung J.
Jeong K.-S.
Kwong H.-L.
Morikawa K.
Wang Z.-M.
Xu D.
Zhang X.-L.
J.
Org. Chem.
1992,
57:
2768
<A NAME="RU12408ST-13">13</A>
The attempted dihydroxylations with
OsO4/NMO and with AD-mix-α provided
a 1:1 to 1:2 mixture of diastereomers with respect to the 3-pentyloxy
group.
<A NAME="RU12408ST-14">14</A>
Hydrogenolysis (10% Pd/C,
EtOAc, r.t., 48 h) of 7a also provided 7b with poor reproducibility probably owing
to poisoning by the accumulated contaminations.
<A NAME="RU12408ST-15">15</A>
Worster PM.
Leznoff CC.
McArthur CR.
J. Org. Chem.
1980,
45:
174
<A NAME="RU12408ST-16">16</A>
Compound 8b: [α]D
²¹.5 -19.2
(c 1.07, CHCl3); mp 142.1-143.5 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 7.85-7.70
(m, 4 H), 6.77 (d, J = 9.8
Hz, 1 H), 4.77-4.72 (m, 1 H), 4.60-4.54 (m, 1
H), 3.80-3.60 (m, 5 H), 3.25-3.14 (m, 2 H), 2.28-2.18 (m,
1 H), 1.98 (s, 3 H), 1.95-1.86 (m, 1 H), 1.75 (br s, 1
H), 1.55-1.30 (m, 5 H), 1.11-0.98 (m, 2 H), 0.78-0.72
(m, 6 H). ¹³C NMR (125 MHz, CDCl3): δ = 171.7,
169.2, 134.2, 131.6, 123.3, 79.2, 75.3, 61.8, 60.4, 52.5, 51.1,
29.2, 26.1, 25.5, 25.3, 22.9, 9.39, 9.37. Anal. Calcd for C22H32N2O6:
C, 62.84, H, 7.67, N, 6.66. Found: C, 62.70, H, 7.85, N, 6.65.
<A NAME="RU12408ST-17">17</A>
Dialdehyde 9 was
pure enough to be used for the next step. However, it was labile
to purification on silica gel column chromatography for combustion
analysis, affording a complex mixture involving cyclized products.
<A NAME="RU12408ST-18A">18a</A>
Anelli PL.
Biffi C.
Montanari F.
Quici S.
J.
Org. Chem.
1987,
52:
2559
<A NAME="RU12408ST-18B">18b</A>
Anelli PL.
Montanari F.
Quici S.
Org. Synth.
1990,
69:
212
<A NAME="RU12408ST-18C">18c</A>
Leanna MR.
Sowin TJ.
Morton HE.
Tetrahedron Lett.
1992,
33:
5029
<A NAME="RU12408ST-19A">19a</A>
Corey EJ.
Danheiser RL.
Chandrasekaran S.
Siret P.
Keck GE.
Gras J.-L.
J. Am. Chem. Soc.
1978,
100:
8031
<A NAME="RU12408ST-19B">19b</A>
Snyder SA.
Corey EJ.
Tetrahedron
Lett.
2006,
47:
2083
<A NAME="RU12408ST-20">20</A>
Compound 10:
obtained as an off-white solid by washing with hot toluene; [α]D
²².5 -46.5
(c 1.10, CHCl3); mp 202.3-202.7 ˚C. ¹H
NMR (500 MHz, CDCl3, data of a mixture of rotamers): δ = 9.55
(s, 0.13 H), 9.53 (s, 0.87 H), 7.86-7.72 (m, 4 H), 6.70
(s, 0.13 H), 6.67 (s, 0.87 H), 5.53 (d, J = 7.6 Hz,
0.87 H), 5.26 (d, J = 7.6
Hz, 0.13 H), 4.95-4.90 (m, 0.87 H), 4.75-4.71
(m, 0.87 H), 4.45-4.38 (m, 1.13 H), 4.20-4.18 (m,
0.13 H), 3.46-3.37 (m, 1 H), 3.05-2.98 (m, 1 H),
2.75-2.65 (m, 1 H), 2.05 (s, 0.4 H), 1.78 (s, 2.6 H), 1.60-1.50
(m, 4 H), 1.00-0.85 (m, 6 H). ¹³C
NMR (125 Hz, CDCl3, data of a mixture of rotamers): δ = 192.3,
170.3, 168.1, 147.6, 138.8, 134.2, 131.6, 128.5, 123.5, 82.5, 74.6,
54.3, 47.8, 26.3, 25.7, 25.5, 23.3, 9.7, 9.4. Anal. Calcd for C22H26N2O5:
C, 66.32; H, 6.58; N, 7.03. Found: C, 66.15; H, 6.72; N, 7.05. HRMS (FAB+): m/z calcd for C22H27N2O5 [MH+]:
399.1920; found: 399.1925.
<A NAME="RU12408ST-21">21</A>
Gonzalez-Bello C.
Coggins JR.
Hawkins AR.
Abell C.
J. Chem. Soc.,
Perkin Trans. 1
1999,
849
<A NAME="RU12408ST-22">22</A>
Evaporation of the volatiles and addition
of a large excess of H2O to the residue provided an off-white
solid, which was collected by filtration and washed successively
with H2O and MeOt-Bu.
Compound 11: obtained as a white solid (mp >280 ˚C)
with poor solubility in organic solvents such as MeOH or CHCl3: [α]D
²5 -58.4
(c 0.54, DMSO). ¹H
NMR (500 MHz, DMSO-d
6): δ = 12.6
(br s, 1 H), 7.92-7.80 (m, 4 H), 6.69 (s, 1 H), 4.38-4.20
(m, 3 H), 3.42-3.10 (m, 2 H), 2.63-2.50 (m, 1
H), 1.50-1.32 (m, 4 H), 0.86 (t, J = 7.3
Hz, 3 H), 0.75 (t, J = 7.3 Hz,
3 H). ¹³C NMR (125 Hz, DMSO-d
6): δ = 169.1,
167.6, 167.0, 137.5, 134.3, 129.0, 123.0, 81.0, 74.7, 51.5, 48.9, 26.6,
25.8, 25.1, 22.4, 9.5, 8.9. Anal. Calcd for C22H26N2O6: C,
63.76; H, 6.32; N, 6.76. Found: C, 63.76; H, 6.45; N, 6.71.
<A NAME="RU12408ST-23">23</A>
Osby JO.
Martin MG.
Ganem B.
Tetrahedron
Lett.
1984,
25:
2093
<A NAME="RU12408ST-24">24</A>
Crude 12a deposited
efficiently on dilution of the reaction mixture with a large excess
of diluted HCl. Filtration and washing with water provided pure 12a as a white solid: [α]D
²².8 -79.2
(c 1.07, CHCl3-MeOH = 4:1);
mp 180.4-180.8 ˚C. ¹H NMR
(500 MHz, CD3OD): δ = 7.43-7.23
(m, 4 H), 6.73 (br s, 1 H), 4.75-4.50 (m, 2 H), 4.25-3.80
(m, 3 H), 3.37-3.33 (m, 1 H), 2.73-2.65 (m, 1
H), 2.33-2.27 (m, 1 H), 1.50-1.35 (m, 4 H), 0.86-0.77
(m, 6 H). ¹³C NMR (125 Hz, CD3OD): δ = 173.9,
172.0, 169.4, 140.9, 139.1, 136.3, 131.7, 130.7, 129.8, 128.7, 128.6,
83.8, 77.3, 63.5, 55.9, 31.5, 27.3, 26.8, 23.0, 9.9, 9.6. Anal.
Calcd for C22H30N2O6: C,
63.14; H, 7.23; N, 6.69. Found: C, 62.89; H, 7.37; N, 6.73.
<A NAME="RU12408ST-25">25</A>
Dilution of the reaction mixture with
a large excess of water deposited a white solid, which was washed
successively with H2O and MeOt-Bu
to give unmingled 12b as a white solid: [α]D
²³.0 -48.0
(c 1.11, CHCl3); mp 209.3-210 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 7.43-7.23
(m, 4 H), 6.73 (br s, 1 H), 4.75-4.50 (m, 2 H), 4.25-3.80
(m, 3 H), 3.37-3.33 (m, 1 H), 2.73-2.65 (m, 1
H), 2.33-2.27 (m, 1 H), 1.50-1.35 (m, 4 H), 0.86-0.77
(m, 6 H). ¹³C NMR (125 Hz, CDCl3): δ = 171.5, 169.9,
165.9, 139.8, 137.8, 135.1, 131.2, 130.7, 129.1, 128.1, 127.9, 82.2,
75.7, 64.4, 60.9, 54.3, 48.7, 30.5, 26.2, 25.6, 22.8, 14.1, 9.6,
9.2. Anal. Calcd for C24H34N2O6:
C, 64.55; H, 7.67; N, 6.27. Found: C, 64.25; H, 8.03; N, 6.21.
<A NAME="RU12408ST-26">26</A>
Oseltamivir (1),
obtained as a white semi-solid: [α]D
²5.0 -55.8
(c 2.05, CHCl3). ¹H
NMR (500 MHz, CDCl3): δ = 6.79 (br
s, 1 H), 5.48 (d, J = 7.6
Hz, 1 H), 4.25-4.18 (m, 3 H), 3.55-3.48 (m, 1
H), 3.38-3.32 (m, 1 H), 3.27-3.20 (m, 1 H), 2.75
(dd, J = 17.9,
5.2 Hz, 1 H), 2.19-2.11 (m, 1 H), 2.04 (s, 3 H), 1.60-1.47
(m, 6 H), 1.29 (t, J = 7.1
Hz, 3 H), 0.95-0.88 (m, 6 H). ¹³C
NMR (125 Hz, CDCl3): δ = 170.9, 166.3, 137.5,
129.5, 81.6, 74.8, 60.8, 58.9, 49.2, 33.6, 26.2, 25.7, 23.6, 14.2,
9.5, 9.3. ¹H NMR and ¹³C
NMR spectra and optical rotation value were in full accordance with
those of the authentic sample obtained through a basic extraction
(sat. aq NaHCO3-5% aq Na2CO3-CHCl3)
from commercial Tamiflu: [α]D
²³.0 -56.1
(c 1.24, CHCl3). ¹H
NMR (500 MHz, CDCl3): δ = 6.79 (br
s, 1 H), 5.79 (d, J = 7.95
Hz, 1 H), 4.26-4.17 (m, 3 H), 3.57-3.49 (m, 1
H), 3.38-3.32 (m, 1 H), 3.26-3.18 (m, 1 H), 2.75
(dd, J = 17.9,
4.9 Hz, 1 H), 2.18-2.10 (m, 1 H), 2.04 (s, 3 H), 1.66-1.60
(m, 2 H), 1.56-1.47 (m, 4 H), 1.29 (t, J = 7.0
Hz, 3 H), 0.95-0.87 (m, 6 H). ¹³C
NMR (125 Hz, CDCl3): δ = 170.9, 166.3,
137.5, 129.5, 81.6, 74.8, 60.8, 59.0, 49.2, 33.6, 26.2, 25.7, 23.6,
14.2, 9.5, 9.3.